Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies

[1]  K. Blennow,et al.  Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele , 2005, Journal of Neural Transmission.

[2]  J. Häggendal.  Noradrenaline and dopamine-beta-hydroxylase levels in rat salivary glands after preganglionic nerve stimulation: Evidence for re-use of amine storage granules in transmitter release , 2005, Journal of Neural Transmission.

[3]  W. Honer,et al.  Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus , 2004, Acta Neuropathologica.

[4]  E. Masliah,et al.  Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease , 2004, Acta Neuropathologica.

[5]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[6]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[7]  L. Thal,et al.  Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD , 2003, Neurology.

[8]  E. Masliah,et al.  α‐Synuclein up‐regulates expression of caveolin‐1 and down‐regulates extracellular signal‐regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease , 2003 .

[9]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[10]  P. Coleman,et al.  Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.

[11]  Smita Patel,et al.  Golgi Fragmentation Occurs in the Cells with Prefibrillar α-Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion* , 2002, The Journal of Biological Chemistry.

[12]  S. Totterdell,et al.  Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson’s disease , 2002, Brain Research.

[13]  W. Meier-Ruge,et al.  Deafferentative Synaptopathology in Physiological Aging and Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[14]  P. Greengard,et al.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.

[15]  Richard Paylor,et al.  Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.

[16]  C. Rabiner,et al.  Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer’s disease , 2002, Neuroscience.

[17]  E. Masliah,et al.  Fibroblast Growth Factor 1 Regulates Signaling via the Glycogen Synthase Kinase-3β Pathway , 2002, The Journal of Biological Chemistry.

[18]  B. Hyman,et al.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. , 2002, Archives of neurology.

[19]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Masters,et al.  Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease , 2002 .

[21]  T. Iwatsubo.  [alpha-synuclein and Parkinson's disease]. , 2002, Seikagaku. The Journal of Japanese Biochemical Society.

[22]  Bruce A. Yankner,et al.  Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.

[23]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[24]  R. Doms,et al.  β-Secretase Processing in the Trans-Golgi Network Preferentially Generates Truncated Amyloid Species That Accumulate in Alzheimer's Disease Brain* , 2002, The Journal of Biological Chemistry.

[25]  Y. Sung,et al.  α-Synuclein Interacts with Phospholipase D Isozymes and Inhibits Pervanadate-induced Phospholipase D Activation in Human Embryonic Kidney-293 Cells* , 2002, The Journal of Biological Chemistry.

[26]  A. Björklund,et al.  Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System , 2002, The Journal of Neuroscience.

[27]  E. Masliah,et al.  α-Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells* , 2002, The Journal of Biological Chemistry.

[28]  Patrik Brundin,et al.  Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. , 2002, Nature reviews. Neuroscience.

[29]  Jürgen Götz,et al.  Alzheimer's and Parkinson's disease--overlapping or synergistic pathologies? , 2002, Trends in molecular medicine.

[30]  C. Masters,et al.  Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. , 2002, Annals of neurology.

[31]  R. Doms,et al.  Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. , 2002, The Journal of biological chemistry.

[32]  J. Trojanowski,et al.  Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. , 2002, Neuron.

[33]  M. Mattson,et al.  Presenilins and APP in neuritic and synaptic plasticity , 2002, NeuroMolecular Medicine.

[34]  I. Kanazawa,et al.  α-Synuclein Affects the MAPK Pathway and Accelerates Cell Death* , 2001, The Journal of Biological Chemistry.

[35]  Makoto Hashimoto,et al.  β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Wolfe,et al.  A Portrait of Alzheimer Secretases--New Features and Familiar Faces , 2001, Science.

[37]  V. Bigl,et al.  Neuronal and glial β‐secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology , 2001, Journal of neuroscience research.

[38]  I. Kanazawa,et al.  α‐Synuclein forms a complex with transcription factor Elk‐1 , 2001, Journal of neurochemistry.

[39]  M. Linial,et al.  Involvement of extracellular signal-regulated kinase (ERK) in pardaxin-induced dopamine release from PC12 cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[40]  E. Masliah,et al.  Reduced Neuritic Outgrowth and Cell Adhesion in Neuronal Cells Transfected with Human α-Synuclein , 2001, Molecular and Cellular Neuroscience.

[41]  E. Masliah,et al.  Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.

[42]  S. Scheff,et al.  Alzheimer's disease-related synapse loss in the cingulate cortex. , 2001, Journal of Alzheimer's disease : JAD.

[43]  L. Mucke,et al.  beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Mileusnic,et al.  APP is required during an early phase of memory formation , 2000, The European journal of neuroscience.

[45]  L. McConlogue,et al.  Recent Advances in the Understanding of the Processing of APP to Beta Amyloid Peptide , 2000, Annals of the New York Academy of Sciences.

[46]  Sarah J. Tabrizi,et al.  Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity , 2000 .

[47]  Mark P. Mattson,et al.  Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.

[48]  D. Madison,et al.  A Novel SNAP25–Caveolin Complex Correlates with the Onset of Persistent Synaptic Potentiation , 2000, The Journal of Neuroscience.

[49]  E. Masliah,et al.  α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress , 2000 .

[50]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[51]  G. Glosser,et al.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.

[52]  Y. Yang,et al.  Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation , 2000, Neuroscience.

[53]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[54]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[55]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[56]  E. Masliah,et al.  alpha-synuclein promotes mitochondrial deficit and oxidative stress. , 2000, The American journal of pathology.

[57]  Y. Yang,et al.  Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. , 2000, Neuroscience.

[58]  S. Tabrizi,et al.  Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. , 2000, Human molecular genetics.

[59]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[60]  J. Engelman,et al.  Caveolins, Liquid-Ordered Domains, and Signal Transduction , 1999, Molecular and Cellular Biology.

[61]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[62]  E. Masliah,et al.  Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease , 1999, Brain pathology.

[63]  P. Lansbury,et al.  Amyloid diseases: abnormal protein aggregation in neurodegeneration. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Parton,et al.  Membrane microdomains and caveolae. , 1999, Current opinion in cell biology.

[65]  L. Petrucelli,et al.  α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins , 1999, The Journal of Neuroscience.

[66]  D. Storm,et al.  Making New Connections Role of ERK/MAP Kinase Signaling in Neuronal Plasticity , 1999, Neuron.

[67]  P. Lansbury.  Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Salmon,et al.  Neuropathological Correlates of Dementia in Alzheimer’s Disease , 1999 .

[69]  P Choi,et al.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  R. Jakes,et al.  Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's disease , 1998, FEBS letters.

[71]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[72]  Takeshi Iwatsubo,et al.  Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia , 1998, Cell Death and Differentiation.

[73]  Makoto Hashimoto,et al.  Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease , 1998, Brain Research.

[74]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[75]  L. Mucke,et al.  Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport , 1998, The Journal of Biological Chemistry.

[76]  S. Love,et al.  Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer’s disease and dementia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[77]  M. Lisanti,et al.  Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[78]  W. Honer,et al.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. , 1998, The American journal of pathology.

[79]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[80]  S. Younkin,et al.  The APP and PS1/2 Mutations Linked to Early Onset Familial Alzheimer’s Disease Increase the Extracellular Concentration of Aβ1–42(43) , 1998 .

[81]  S. Tsuji,et al.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. , 1998, Neuroscience letters.

[82]  E. Masliah,et al.  Mechanisms of synaptic pathology in Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[83]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[84]  Hitoshi Takahashi,et al.  NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.

[85]  S. Parsons,et al.  Roles for Protein Kinase C and Mitogen‐Activated Protein Kinase in Nicotine‐Induced Secretion from Bovine Adrenal Chromaffin Cells , 1997, Journal of neurochemistry.

[86]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[87]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[88]  K. Blennow,et al.  Synaptic Pathology in Alzheimer’s Disease , 1997 .

[89]  S. Younkin.  [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)]. , 1997, Rinsho shinkeigaku = Clinical neurology.

[90]  L. Hansen.  The Lewy body variant of Alzheimer disease. , 1997, Journal of neural transmission. Supplementum.

[91]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[92]  J. Hardy,et al.  Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.

[93]  L. Mucke,et al.  Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[94]  D. Selkoe,et al.  The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Protein a , 1996 .

[95]  D. Galasko,et al.  Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[96]  D. Selkoe,et al.  The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. , 1996, Annals of the New York Academy of Sciences.

[97]  W. Honer,et al.  Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.

[98]  E. Masliah.  Natural evolution of the neurodegenerative alterations in Alzheimer's disease , 1995, Neurobiology of Aging.

[99]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[100]  D. Selkoe,et al.  beta-Amyloid, protein processing and Alzheimer's disease. , 1995, Arzneimittel-Forschung.

[101]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[102]  B. Anderson.  DENDRITIC CORRELATES OF DEMENTIA SEVERITY IN ALZHEIMER'S DISEASE , 1995 .

[103]  D.G. Jones,et al.  An Analysis of Contemporary Morphological Concepts of Synaptic Remodelling in the CNS: Perforated Synapses Revisited , 1995, Reviews in the neurosciences.

[104]  W. Honer,et al.  Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease , 1994, Brain Research.

[105]  D. Price,et al.  Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. , 1994, The American journal of pathology.

[106]  L. R. Hill,et al.  Hippocampal connectivity and Alzheimer's dementia , 1994, Neurology.

[107]  L A Hansen,et al.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.

[108]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[109]  J. Kimura,et al.  Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains , 1994, Brain Research.

[110]  E. Masliah,et al.  Structural basis of the cognitive alterations in Alzheimer disease. , 1994 .

[111]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[112]  D. Sparks,et al.  Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease , 1993, Annals of neurology.

[113]  Michael Alford,et al.  Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies , 1993, Brain Research.

[114]  D. Selkoe,et al.  Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[115]  K. Beyreuther,et al.  Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. , 1993, Dementia.

[116]  D. Price,et al.  Synapse loss in the temporal lobe in Alzheimer's disease , 1993, Annals of neurology.

[117]  E. Masliah,et al.  Amyloid precursor protein is localized in growing neurites of neonatal rat brain , 1992, Brain Research.

[118]  J. Trojanowski,et al.  Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease , 1992, Neurology.

[119]  Brian J Cummings,et al.  Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in alzheimer's disease , 1992, Neuroscience.

[120]  E. Masliah,et al.  Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease , 1992, Brain Research.

[121]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[122]  K. Jellinger,et al.  Synaptic pathology in alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles , 1992, Neuroscience.

[123]  M. Vandermeeren,et al.  Neurite sprouting and cytoskeletal pathology in Alzheimer's disease: a comparative study with monoclonal antibodies to growth associated protein B-50 and paired helical filaments , 1992 .

[124]  Walter Schubert,et al.  Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites , 1991, Brain Research.

[125]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[126]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[127]  E. Masliah,et al.  Abnormal brain spectrin immunoreactivity in sprouting neurons in Alzheimer disease , 1991, Neuroscience Letters.

[128]  Fred H. Gage,et al.  Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat , 1991, Experimental Neurology.

[129]  Michael Alford,et al.  Patterns of aberrant sprouting in alzheimer's disease , 1991, Neuron.

[130]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[131]  Carl W. Cotman,et al.  The Role of Misdirected Plasticity in Plaque Biogenesis and Alzheimer's Disease Pathology , 1991 .

[132]  E. Masliah,et al.  Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. , 1991, The American journal of pathology.

[133]  D. Price,et al.  Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. , 1990, The American journal of pathology.

[134]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[135]  D. Price,et al.  RELATIONSHIPS OF ABNORMAL NEURONAL PROCESSES AND AMYLOID IN PLAQUES IN AGED MONKEYS: 146 , 1990 .

[136]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[137]  K. Jellinger,et al.  A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease , 1990, FEBS letters.

[138]  R. Katzman.,et al.  Alzheimer's disease is a degenerative disorder , 1989, Neurobiology of Aging.

[139]  E. Masliah,et al.  Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease , 1989, Neuroscience Letters.

[140]  David A. Drachman,et al.  Synaptic loss in Alzheimer's disease and other dementias , 1989, Neurology.

[141]  D. Dickson,et al.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. , 1988, The American journal of pathology.

[142]  C. Cotman,et al.  Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease. , 1988, Advances in neurology.

[143]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[144]  R. Mayeux,et al.  Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. , 1987, Acta neuropathologica.

[145]  C. Cotman,et al.  Senile plaques as aberrant sprout-stimulating structures , 1986, Experimental Neurology.

[146]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[147]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[148]  J. Eccles.  The Cerebral Neocortex , 1984 .

[149]  O. Steward,et al.  Synaptic replacement in the dentate gyrus after unilateral entorhinal lesion: electron microscopic analysis of the extent of replacement of synapses by the remaining entorhinal cortex , 1977, Journal of neurocytology.

[150]  Gary Lynch,et al.  An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. II. Reappearance of morphologically normal synaptic contacts , 1976, Brain Research.

[151]  G. Lynch,et al.  Spine Loss and Regrowth in Hippocampus following Deafferentation , 1974, Nature.

[152]  G. Lynch,et al.  A quantitative electron microscopic study of synaptogenesis in the dentate gyrus of the rat. , 1973, Brain research.

[153]  G. Lynch,et al.  Synaptic rearrangement in the dentate gyrus: histochemical evidence of adjustments after lesions in immature and adult rats. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[154]  I. Evangelista,et al.  THE CONTRIBUTION OF ALTERED SYNAPSES IN THE SENILE PLAQUE: AN ELECTRON MICROSCOPIC STUDY IN ALZHEIMER'S DEMENTIA , 1967, Journal of neuropathology and experimental neurology.

[155]  R. Terry,et al.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.